AI Cong 1,2 , LI Guangxiao 1,2 , ZHOU Bo 1,2 , ZHANG Peng 1,2 , HE Qiao 1,2 , SHI Jingpu 1,2
  • 1. Department of Clinical Epidemiology and Evidence-Based Medicine, the First Alienated Hospital, China Medical University, Shenyang, 110001, P.R.China;
  • 2. Evidence-Based Medicine Center of Liaoning Province, Shenyang, 110001, P.R.China;
SHI Jingpu, Email: sjp56@yahoo.com
Export PDF Favorites Scan Get Citation

Objective  To estimate the incidence of post-myocardial infarction depression among Chinese acute myocardial infarction (AMI) patients by meta-analysis and to provide references for the management of AMI patients. Methods  We searched databases including PubMed, The Cochrane Library (Issue 6, 2016), CNKI, CBM, WanFang Data and VIP from January 2000 to July 2016, to collect literature regarding the incidence of post-myocardial infarction depression among patients with AMI. Two reviewers independently screened literature, extracted data and evaluated the methodological quality of the included studies. Then meta-analysis was performed by using Comprehensive Meta Analysis (CMA) 2.0 software. Results  Totally, 22 cross-sectional studies were included, involving 2 986 AMI patients, of which1 239 were post-myocardial infarction depression patients. The overall incidence of post-myocardial infarction depression among the AMI patients was 42.7% (95%CI 36.3% to 49.4%). There was no statistical differences observed when the studies were stratified by sex, regions, scales and years (allP values>0.05). Conclusion  In China, the incidence of post-myocardial infarction depression is high and rising year by year roughly among AMI patients. The status should be paid more attention.

Citation: AI Cong, LI Guangxiao, ZHOU Bo, ZHANG Peng, HE Qiao, SHI Jingpu. The incidence of post-myocardial infarction depression among acute myocardial infarction patients in China during the 2000s: a meta-analysis. Chinese Journal of Evidence-Based Medicine, 2017, 17(1): 47-51. doi: 10.7507/1672-2531.201611084 Copy

  • Previous Article

    Trastuzumab combined with chemotherapy for Her-2 positive patients with advanced gastric cancer: a meta-analysis
  • Next Article

    Efficacy and safety of oral polyethylene glycol versus sodium phosphate solution in capsule endoscopy: a systematic review